» Articles » PMID: 37940918

Comparison of Short-term Efficacy Analysis of Medium-rectal Cancer Surgery with Robotic Natural Orifice Specimen Extraction and Robotic Transabdominal Specimen Extraction

Overview
Journal BMC Surg
Publisher Biomed Central
Specialty General Surgery
Date 2023 Nov 8
PMID 37940918
Authors
Affiliations
Soon will be listed here.
Abstract

Background: With the development of minimally invasive technology, the trauma caused by surgery get smaller, At the same time, the specimen extraction surgery through the natural orifice is more favored by experts domestically and abroad, robotic surgery has further promoted the development of specimen extraction surgery through the natural orifice. The aim of current study is to compare the short-term outcomes of robotic-assisted natural orifice specimen extraction (NOSES ) and transabdominal specimen extraction(TRSE ) in median rectal cancer surgery.

Methods: From January 2020 to January 2023, 87 patients who underwent the NOSES or TRSE at the First Affiliated Hospital of Nanchang University were included in the study, 4 patients were excluded due to liver metastasis. Of these, 50 patients were in the TRSE and 33 patients in the NOSES. Short-term efficacy was compared in the two groups.

Results: The NOSES group had less operation time (P < 0.001), faster recovery of gastrointestinal function (P < 0.001), shorter abdominal incisions (P < 0.001), lower pain scores(P < 0.001). lower Inflammatory indicators of the white blood cell count and C-reactive protein content at 1, 3, and 5 days after surgery (P < 0.001, P = 0.037). There were 9 complications in the NOSES group and 11 complications in the TRSE group(P = 0.583). However, there were no wound complications in the NOSES group. The number of postoperative hospital stays seems to be same in the two groups. And there was no significant difference in postoperative anus function (P = 0.591).

Conclusions: This study shows that NOSES and TRSE can achieve similar radical treatment effects, NOSES is a feasible and safe way to take specimens for rectal cancer surgery in accordance with the indication for NOSES.

References
1.
Leung K, Lai P, Ho R, Meng W, Yiu R, Lee J . Systemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma: A prospective randomized trial. Ann Surg. 2000; 231(4):506-11. PMC: 1421025. DOI: 10.1097/00000658-200004000-00008. View

2.
Ye S, Zhu W, Liu D, Lei X, Jiang Q, Hu H . Robotic- laparoscopic-assisted proctectomy for locally advanced rectal cancer based on propensity score matching: Short-term outcomes at a colorectal center in China. World J Gastrointest Oncol. 2020; 12(4):424-434. PMC: 7191331. DOI: 10.4251/wjgo.v12.i4.424. View

3.
Cheng C, Rezac C . The role of robotics in colorectal surgery. BMJ. 2018; 360:j5304. DOI: 10.1136/bmj.j5304. View

4.
Garcia L, Taylor J, Atallah C . Update on Minimally Invasive Surgical Approaches for Rectal Cancer. Curr Oncol Rep. 2021; 23(10):117. DOI: 10.1007/s11912-021-01110-1. View

5.
Feng Q, Yuan W, Li T, Tang B, Jia B, Zhou Y . Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol. 2022; 7(11):991-1004. DOI: 10.1016/S2468-1253(22)00248-5. View